Mannanase variants and polynucleotides encoding same
Summary
USPTO granted patent US12595472B2 to BASF SE for mannanase enzyme variants at least 75% identical to SEQ ID NO: 2 or 3, including encoding polynucleotides, expression constructs, and host cells. The patent, filed February 12, 2021, contains 14 claims and is classified under CPC C12N 9/2488.
What changed
USPTO issued patent grant US12595472B2 to BASF SE covering mannanase enzyme variants with at least 75% sequence identity to specified sequences, along with related polynucleotides, expression constructs, and host cells containing these elements. The patent names seven inventors and grants exclusive rights to the assignee.
This patent grant establishes intellectual property rights that may restrict others from making, using, or commercializing similar mannanase variants without BASF SE's permission. Competitors developing enzyme products in related applications should review the patent claims for potential infringement risks or consider licensing opportunities.
What to do next
- Monitor for updates
Archived snapshot
Apr 7, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Mannanase variants
Grant US12595472B2 Kind: B2 Apr 07, 2026
Assignee
BASF SE
Inventors
Katie Kline, Amanda Rae Logue, Asfia Qureshi, Cindy Hoang, Jesper Nielsen, Mark Miller, James Garrett Bonner
Abstract
A mannanase at least 75% identical to SEQ ID NO: 2 or SEQ ID NO: 3, a polynucleotide encoding the mannanase, an expression construct comprising the polynucleotide, and a host cell comprising the polynucleotide or the expression construct.
CPC Classifications
C12N 9/2488
Filing Date
2021-02-12
Application No.
17799049
Claims
14
Related changes
Get daily alerts for ChangeBridge: Patent Grants - Biotech (C12N)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The plain-English summary, classification, and "what to do next" steps are AI-generated from the original text. Cite the source document, not the AI analysis.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ChangeBridge: Patent Grants - Biotech (C12N) publishes new changes.